PMID: 9184650Jun 1, 1997Paper

Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis

Journal of Neuroimmunology
K VandenbroeckL M Grimaldi

Abstract

An epistatic gene interaction has been advocated to explain disease susceptibility in multiple sclerosis (MS). Cytokine genes are possible candidates due to the central role played by cytokines in the regulation of the immune-mediated pathogenetic process leading to central nervous system demyelination in these patients. Since interleukin (IL)-4 gene polymorphisms have been associated with immune-mediated diseases, we have analysed the relationship between a variable number of tandem repeat polymorphism of the IL-4 gene and clinical and physiological features of 256 sporadic MS patients and 146 healthy controls. Genotype frequencies were similar between the MS group and healthy controls. However, in MS patients a positive and significant correlation (r = 0.91; p < 0.001) was found between the carriage rate of the IL-4 B1 allele (from 0.21 to 0.36) and age of disease onset. No association was found between IL-4 alleles and disease progression, sex or ethnic background of the patients. Our results show that the IL-4 B1 allele is associated with late onset of MS and therefore might represent a modifier of age of onset rather than a susceptibility factor for patients with MS.

Citations

Jul 25, 2003·Archives of Pharmacal Research·Byung Yong KangNam Joo Ha
Aug 11, 2005·European Archives of Psychiatry and Clinical Neuroscience·Markus J SchwarzNorbert Müller
Aug 13, 2008·Journal of Molecular Neuroscience : MN·Jae-Young Um, Hyung-Min Kim
Jun 19, 2013·Journal of Molecular Neuroscience : MN·Nursah BasolSuheyla Uzun Kaya
Feb 21, 2004·Journal of Neuroimmunology·Fuencisla MatesanzAntonio Alcina
Jun 24, 2000·Journal of the Neurological Sciences·G V McDonnellC A Graham
Sep 2, 2000·Journal of Neuroimmunology·G MartinoG Comi
Apr 2, 2003·Journal of Neuroimmunology·Orhun H KantarciBrian G Weinshenker
Jan 23, 1999·Journal of Neuroimmunology·D HuangA K Lefvert
Mar 14, 2000·Journal of Neuroimmunology·F L SciaccaL M Grimaldi
Jun 26, 2003·Trends in Pharmacological Sciences·Koen Vandenbroeck, An Goris
Nov 19, 2002·Pediatric Neurology·Fuu-Jen TsaiChang-Hai Tsai
Jan 23, 1999·Current Opinion in Immunology·S Sawcer, P N Goodfellow
Mar 14, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M JahromiA Demaine
Dec 22, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A Compston
Jun 2, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·A Compston
Oct 7, 2008·Journal of Periodontology·Lydie Izakovicova HollaJiri Vanek
Mar 7, 2002·Journal of Neuroimmunology·Orhun H KantarciBrian G Weinshenker
Jul 18, 2008·Journal of Neuroimmunology·Sreeram V RamagopalanGeorge C Ebers
Jul 28, 2004·American Journal of Reproductive Immunology : AJRI·Yasuaki SaijoReiko Kishi
Jun 25, 2008·American Journal of Reproductive Immunology : AJRI·Yoon Kyong Choi, Joanne Kwak-Kim
Feb 14, 2007·Acta Neurologica Scandinavica·E Kamali-SarvestaniB Gharesi-Fard
Feb 15, 2005·Neurobiology of Aging·Andis KlegerisPatrick L McGeer
Sep 20, 2005·Journal of Neuroimmunology·Elena UrcelayEmilio G de la Concha
Oct 25, 2014·Implant Dentistry·Suzane C PigossiRaquel M Scarel-Caminaga
Jun 24, 2005·Genes and Immunity·J R Oksenberg, L F Barcellos
Jul 10, 2018·Immunological Investigations·Shamsolmoulouk NajafiNima Rezaei

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.